See more : Concord Biotech Limited (CONCORDBIO.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Hextar Healthcare Berhad (7803.KL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hextar Healthcare Berhad, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Creative Global Technology Holdings Limited Ordinary Shares (CGTL) Income Statement Analysis – Financial Results
- PT Prasidha Aneka Niaga Tbk (PSDN.JK) Income Statement Analysis – Financial Results
- Tecsys Inc. (TCYSF) Income Statement Analysis – Financial Results
- Nippon Prologis REIT, Inc. (NPONF) Income Statement Analysis – Financial Results
- Media Asia Group Holdings Limited (8075.HK) Income Statement Analysis – Financial Results
Hextar Healthcare Berhad (7803.KL)
About Hextar Healthcare Berhad
Hextar Healthcare Berhad, an investment holding company, manufactures, trades, and sells In-Vitro Diagnostic (IVD) medical devices in Malaysia and Europe. It operates through Gloves Operation and Medical Devices Operation segments. The company offers natural rubber, synthetic rubber, and nitrile disposable gloves for household, industrial, and professional applications. It is also involved in the trading and sale of gloves, household and kitchen items, and personal protective products, as well as invests in properties. The company was formerly known as Rubberex Corporation (M) Berhad. The company was founded in 1987 and is headquartered in Ipoh, Malaysia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 154.76M | 179.04M | 514.67M | 416.64M | 219.49M | 205.42M | 403.56M | 311.14M | 300.24M | 296.41M | 325.34M | 376.55M | 373.70M | 343.26M | 317.63M | 274.51M | 144.93M | 121.39M |
| Cost of Revenue | 154.54M | 40.60M | 299.06M | 158.91M | 120.60M | 119.85M | 234.69M | 165.17M | 156.85M | 174.63M | 224.99M | 247.47M | 257.43M | 225.64M | 189.75M | 172.92M | 79.38M | 64.25M |
| Gross Profit | 223.68K | 138.44M | 215.62M | 257.74M | 98.89M | 85.57M | 168.88M | 145.96M | 143.39M | 121.78M | 100.35M | 129.07M | 116.27M | 117.62M | 127.87M | 101.60M | 65.55M | 57.14M |
| Gross Profit Ratio | 0.14% | 77.32% | 41.89% | 61.86% | 45.06% | 41.66% | 41.85% | 46.91% | 47.76% | 41.09% | 30.85% | 34.28% | 31.11% | 34.27% | 40.26% | 37.01% | 45.23% | 47.07% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 380.91K | 301.18K | 300.69K | 277.10K | 275.68K | 255.87K | 539.49K | 536.77K | 511.55K | 440.30K | 426.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 46.89M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 380.91K | 301.18K | 300.69K | 47.16M | 275.68K | 255.87K | 539.49K | 536.77K | 511.55K | 440.30K | 426.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 99.17M | 124.43M | 95.29M | 77.43M | -32.48K | 142.19M | 123.03M | 10.13K | 6.00K | -19.99K | 95.05M | 96.66M | 92.47M | 94.84M | 81.76M | 64.16M | 46.80M |
| Operating Expenses | 65.80M | 99.47M | 124.73M | 95.29M | 77.71M | 74.00M | 142.73M | 123.56M | 118.05M | 96.92M | 90.32M | 95.05M | 96.66M | 92.47M | 94.84M | 81.76M | 64.16M | 46.80M |
| Cost & Expenses | 156.49M | 140.07M | 423.79M | 254.19M | 198.31M | 193.85M | 377.41M | 288.74M | 274.90M | 271.55M | 315.31M | 342.52M | 354.09M | 318.11M | 284.60M | 254.68M | 143.54M | 111.05M |
| Interest Income | 34.91K | 7.65K | 10.18K | 1.51M | 849.82K | 188.38K | 9.53K | 1.54M | 0.00 | 11.63K | 20.28K | -1.05M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 822.61K | 195.78K | 102.56K | 265.30K | 1.87M | 2.79M | 3.97M | 2.74M | 3.33M | 3.70M | 5.24M | 7.05M | 9.69M | 8.64M | 8.03M | 7.04M | 5.45M | 2.33M |
| Depreciation & Amortization | 19.77M | 14.86M | 13.33M | 8.79M | 7.83M | 11.96M | 11.36M | 22.81M | 20.40M | 16.89M | 15.92M | 15.27M | 15.51M | 16.74M | 15.06M | 13.34M | 11.92M | 10.38M |
| EBITDA | -53.37M | -47.71M | 250.63M | 170.52M | 25.99M | 25.24M | 26.82M | 52.74M | 44.03M | 40.00M | 25.53M | 48.23M | 35.34M | 35.76M | 46.63M | 32.49M | 12.58M | 20.42M |
| EBITDA Ratio | -34.49% | -16.53% | 47.54% | 41.16% | 11.65% | 17.99% | 10.65% | 16.89% | 14.74% | 13.50% | 8.61% | 13.09% | 9.46% | 12.27% | 15.22% | 12.17% | 17.23% | 23.31% |
| Operating Income | -27.15M | -44.79M | 231.37M | 162.52M | 17.66M | 11.57M | 26.15M | 22.37M | 25.29M | 21.07M | 10.58M | 34.02M | 19.61M | 25.15M | 33.03M | 19.84M | 1.39M | 10.34M |
| Operating Income Ratio | -17.54% | -25.02% | 44.96% | 39.01% | 8.05% | 5.63% | 6.48% | 7.19% | 8.42% | 7.11% | 3.25% | 9.04% | 5.25% | 7.33% | 10.40% | 7.23% | 0.96% | 8.52% |
| Total Other Income/Expenses | -46.40M | -18.39M | 5.41M | -1.48M | -1.92M | -1.43M | -8.75M | 4.07M | -5.04M | -4.53M | -5.66M | -7.47M | -9.45M | -15.00M | -9.73M | -7.95M | -5.87M | -2.13M |
| Income Before Tax | -73.55M | -63.18M | 236.78M | 161.04M | 15.74M | 10.14M | 15.24M | 26.47M | 20.31M | 16.54M | 4.37M | 25.91M | 11.61M | 10.15M | 23.30M | 11.88M | -4.48M | 8.21M |
| Income Before Tax Ratio | -47.52% | -35.29% | 46.01% | 38.65% | 7.17% | 4.94% | 3.78% | 8.51% | 6.76% | 5.58% | 1.34% | 6.88% | 3.11% | 2.96% | 7.33% | 4.33% | -3.09% | 6.76% |
| Income Tax Expense | -9.26M | -7.49M | 51.04M | 29.86M | 4.39M | 1.46M | 2.06M | 5.58M | 5.41M | 6.41M | 3.96M | 3.88M | 3.12M | 2.00M | 727.33K | 2.23M | 230.44K | 1.63M |
| Net Income | -64.38M | -55.69M | 185.74M | 131.18M | 11.35M | -52.09M | 13.17M | 20.89M | 14.90M | 10.13M | 417.70K | 22.03M | 8.91M | 6.60M | 17.31M | 8.63M | -1.63M | 6.88M |
| Net Income Ratio | -41.60% | -31.10% | 36.09% | 31.48% | 5.17% | -25.35% | 3.26% | 6.71% | 4.96% | 3.42% | 0.13% | 5.85% | 2.38% | 1.92% | 5.45% | 3.14% | -1.12% | 5.67% |
| EPS | -0.06 | -0.06 | 0.22 | 0.16 | 0.02 | -0.07 | 0.02 | 0.03 | 0.02 | 0.01 | 0.00 | 0.03 | 0.01 | 0.01 | 0.03 | 0.02 | 0.00 | 0.01 |
| EPS Diluted | -0.06 | -0.06 | 0.22 | 0.16 | 0.02 | -0.07 | 0.02 | 0.03 | 0.02 | 0.01 | 0.00 | 0.03 | 0.01 | 0.01 | 0.03 | 0.01 | 0.00 | 0.01 |
| Weighted Avg Shares Out | 1.00B | 895.03M | 851.78M | 802.58M | 756.59M | 756.59M | 733.66M | 687.82M | 683.44M | 681.93M | 696.17M | 637.96M | 606.11M | 604.82M | 517.59M | 474.32M | 476.53M | 473.06M |
| Weighted Avg Shares Out (Dil) | 1.00B | 895.03M | 851.78M | 802.58M | 756.59M | 756.59M | 733.66M | 687.82M | 683.44M | 681.93M | 696.17M | 637.96M | 606.11M | 686.16M | 657.11M | 639.57M | 476.53M | 481.86M |
Source: https://incomestatements.info
Category: Stock Reports